These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 25097914

  • 21. Effect of Hierarchical Cluster Formation on the Viscosity of Concentrated Monoclonal Antibody Formulations Studied by Neutron Scattering.
    Godfrin PD, Zarraga IE, Zarzar J, Porcar L, Falus P, Wagner NJ, Liu Y.
    J Phys Chem B; 2016 Jan 21; 120(2):278-91. PubMed ID: 26707135
    [Abstract] [Full Text] [Related]

  • 22. A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies.
    Esfandiary R, Hayes DB, Parupudi A, Casas-Finet J, Bai S, Samra HS, Shah AU, Sathish HA.
    J Pharm Sci; 2013 Sep 21; 102(9):3089-99. PubMed ID: 23794522
    [Abstract] [Full Text] [Related]

  • 23. Protein-Protein Interactions of Highly Concentrated Monoclonal Antibody Solutions via Static Light Scattering and Influence on the Viscosity.
    Hung JJ, Dear BJ, Karouta CA, Chowdhury AA, Godfrin PD, Bollinger JA, Nieto MP, Wilks LR, Shay TY, Ramachandran K, Sharma A, Cheung JK, Truskett TM, Johnston KP.
    J Phys Chem B; 2019 Jan 31; 123(4):739-755. PubMed ID: 30614707
    [Abstract] [Full Text] [Related]

  • 24. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
    Arora J, Hu Y, Esfandiary R, Sathish HA, Bishop SM, Joshi SB, Middaugh CR, Volkin DB, Weis DD.
    MAbs; 2016 Jan 31; 8(8):1561-1574. PubMed ID: 27560842
    [Abstract] [Full Text] [Related]

  • 25. Trimerization Dictates Solution Opalescence of a Monoclonal Antibody.
    Yang TC, Langford AJ, Kumar S, Ruesch JC, Wang W.
    J Pharm Sci; 2016 Aug 31; 105(8):2328-37. PubMed ID: 27373839
    [Abstract] [Full Text] [Related]

  • 26. Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects.
    Yadav S, Shire SJ, Kalonia DS.
    J Pharm Sci; 2012 Mar 31; 101(3):998-1011. PubMed ID: 22113861
    [Abstract] [Full Text] [Related]

  • 27. Facile Preparation of Stable Antibody-Gold Conjugates and Application to Affinity-Capture Self-Interaction Nanoparticle Spectroscopy.
    Geng SB, Wu J, Alam ME, Schultz JS, Dickinson CD, Seminer CR, Tessier PM.
    Bioconjug Chem; 2016 Oct 19; 27(10):2287-2300. PubMed ID: 27494306
    [Abstract] [Full Text] [Related]

  • 28. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
    Arora J, Hickey JM, Majumdar R, Esfandiary R, Bishop SM, Samra HS, Middaugh CR, Weis DD, Volkin DB.
    MAbs; 2015 Oct 19; 7(3):525-39. PubMed ID: 25875351
    [Abstract] [Full Text] [Related]

  • 29. Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.
    Neergaard MS, Kalonia DS, Parshad H, Nielsen AD, Møller EH, van de Weert M.
    Eur J Pharm Sci; 2013 Jun 14; 49(3):400-10. PubMed ID: 23624326
    [Abstract] [Full Text] [Related]

  • 30. Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions.
    Wei Y, Qi W, Maglalang E, Pelegri-O'Day EM, Luong M, Razinkov V, Sloey C.
    Mol Pharm; 2023 Dec 04; 20(12):6420-6428. PubMed ID: 37906640
    [Abstract] [Full Text] [Related]

  • 31. Biophysical Determinants for the Viscosity of Concentrated Monoclonal Antibody Solutions.
    Mosca I, Pounot K, Beck C, Colin L, Matsarskaia O, Grapentin C, Seydel T, Schreiber F.
    Mol Pharm; 2023 Sep 04; 20(9):4698-4713. PubMed ID: 37549226
    [Abstract] [Full Text] [Related]

  • 32. Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics.
    Avery LB, Wade J, Wang M, Tam A, King A, Piche-Nicholas N, Kavosi MS, Penn S, Cirelli D, Kurz JC, Zhang M, Cunningham O, Jones R, Fennell BJ, McDonnell B, Sakorafas P, Apgar J, Finlay WJ, Lin L, Bloom L, O'Hara DM.
    MAbs; 2018 Sep 04; 10(2):244-255. PubMed ID: 29271699
    [Abstract] [Full Text] [Related]

  • 33. Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.
    Geoghegan JC, Fleming R, Damschroder M, Bishop SM, Sathish HA, Esfandiary R.
    MAbs; 2016 Jul 04; 8(5):941-50. PubMed ID: 27050875
    [Abstract] [Full Text] [Related]

  • 34. Cluster Size and Quinary Structure Determine the Rheological Effects of Antibody Self-Association at High Concentrations.
    Wang W, Lilyestrom WG, Hu ZY, Scherer TM.
    J Phys Chem B; 2018 Feb 22; 122(7):2138-2154. PubMed ID: 29359938
    [Abstract] [Full Text] [Related]

  • 35. Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions.
    Pindrus M, Shire SJ, Kelley RF, Demeule B, Wong R, Xu Y, Yadav S.
    Mol Pharm; 2015 Nov 02; 12(11):3896-907. PubMed ID: 26407030
    [Abstract] [Full Text] [Related]

  • 36. Self-diffusion of a highly concentrated monoclonal antibody by fluorescence correlation spectroscopy: insight into protein-protein interactions and self-association.
    Hung JJ, Zeno WF, Chowdhury AA, Dear BJ, Ramachandran K, Nieto MP, Shay TY, Karouta CA, Hayden CC, Cheung JK, Truskett TM, Stachowiak JC, Johnston KP.
    Soft Matter; 2019 Aug 21; 15(33):6660-6676. PubMed ID: 31389467
    [Abstract] [Full Text] [Related]

  • 37. High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice.
    Kelly RL, Sun T, Jain T, Caffry I, Yu Y, Cao Y, Lynaugh H, Brown M, Vásquez M, Wittrup KD, Xu Y.
    MAbs; 2015 Aug 21; 7(4):770-7. PubMed ID: 26047159
    [Abstract] [Full Text] [Related]

  • 38. Small-scale screening method for low-viscosity antibody solutions using small-angle X-ray scattering.
    Fukuda M, Watanabe A, Hayasaka A, Muraoka M, Hori Y, Yamazaki T, Imaeda Y, Koga A.
    Eur J Pharm Biopharm; 2017 Mar 21; 112():132-137. PubMed ID: 27890509
    [Abstract] [Full Text] [Related]

  • 39. Determination of Interaction Parameters for Reversibly Self-Associating Antibodies: A Comparative Analysis.
    Hopkins MM, Lambert CL, Bee JS, Parupudi A, Bain DL.
    J Pharm Sci; 2018 Jul 21; 107(7):1820-1830. PubMed ID: 29571738
    [Abstract] [Full Text] [Related]

  • 40. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A, Kissmann JM, Joshi SB, Volkin DB, Kashi RS, Middaugh CR.
    J Pharm Sci; 2012 Mar 21; 101(3):1120-35. PubMed ID: 22147527
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.